ClearPoint Neuro, Inc. Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost
ClearPoint Neuro, Inc. (CLPT) had Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost of $1.30 million as of 2025-12-31, per its 10-K filed 2026-03-17.
Financial Statements › Notes › Components of Deferred Tax Assets and Liabilities › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross › Deferred Tax Assets, Tax Deferred Expense
us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost · last filed 2026-03-17
- 2025-12-31: Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost $1.30M.
- 2024-12-31: Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost $1.39M.
- 2023-12-31: Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost $2.19M.
- 2022-12-31: Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost $1.59M.
| Period end | Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost | Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost as first filed |
|---|---|---|
| 2025-12-31 | $1.30M 10-K · filed 2026-03-17 | |
| 2024-12-31 | $1.39M 10-K · filed 2026-03-17 | |
| 2023-12-31 | $2.19M 10-K · filed 2025-02-26 | |
| 2022-12-31 | $1.59M 10-K · filed 2024-03-12 | |
| 2021-12-31 | $2.08M 10-K · filed 2023-03-01 | |
| 2020-12-31 | $2.12M 10-K · filed 2022-03-09 | |
| 2019-12-31 | $1.99M 10-K · filed 2021-03-22 | $1.99M 10-K · filed 2020-03-27 |
| 2018-12-31 | $1.93M 10-K · filed 2020-03-27 | |
| 2017-12-31 | $1.80M 10-K · filed 2019-04-01 | |
| 2016-12-31 | $3.19M 10-K · filed 2018-03-21 | |
| 2015-12-31 | $2.11M 10-K · filed 2017-03-09 | |
| 2014-12-31 | $1.74M 10-K · filed 2016-03-25 | |
| 2013-12-31 | $1.55M 10-K · filed 2015-03-17 | |
| 2012-12-31 | $1.09M 10-K · filed 2014-03-28 | |
| 2011-12-31 | $451.56K 10-K/A · filed 2013-08-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sight Sciences, Inc. (SGHT) | United States | $0.478B | -9.95 |
| NeuroPace Inc (NPCE) | United States | $0.480B | -28.52 |
| CARLSMED, INC. (CARL) | United States | $0.405B | |
| Orthofix Medical Inc. (OFIX) | $0.373B | ||
| TACTILE SYSTEMS TECHNOLOGY INC (TCMD) | United States | $0.519B | 27.16 |
| CERUS CORP (CERS) | United States | $0.525B | -86.40 |
| Orchestra BioMed Holdings, Inc. (OBIO) | United States | $0.356B | -4.39 |
| SHOULDER INNOVATIONS, INC. (SI) | United States | $0.355B | |
| DELCATH SYSTEMS, INC. (DCTH) | United States | $0.558B | 820.33 |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |